By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Medicines Agency (EMA) 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a



Company News
Mylan (MYL) And BioCon (BIOCON.NS) Announce Regulatory Submission For Proposed Biosimilar Trastuzumab Accepted For Review By EMA 8/25/2016 9:39:50 AM
Janssen-Cilag International NV (JNJ) Submits Application To EMA To Expand Use Of DARZALEX (Daratumumab) To Include Combination With Standard Of Care Regimens 8/23/2016 9:40:30 AM
Puma Biotech (PBYI) Announces EMA Validation Of Marketing Authorization Application For PB272 (Neratinib) As Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In Europe 8/22/2016 6:08:21 AM
Portola (PTLA) Announces Validation Of Marketing Authorization Application (MAA) By EMA For Indexxa (Andexanet Alfa), A Factor Xa Inhibitor Antidote 8/19/2016 6:56:45 AM
Cardiome Pharma Corp. (COM.TO) Announces XYDALBA Single Dose Infusion Approval By EMA 8/10/2016 6:55:25 AM
Sanofi (SNY) And Regeneron (REGN) Announce EMA Acceptance For Review Of Marketing Authorisation Application For Sarilumab 8/1/2016 8:55:03 AM
Omeros (OMER) Confirms OMS721 Phase 3 Development Plan With EMA 7/28/2016 8:16:51 AM
DNAtrix, Inc. Receives EMA PRIME Designation 7/27/2016 8:21:35 AM
NewLink Genetics (NLNK) Announces Merck & Co. (MRK) Receives Breakthrough Therapy Designation From FDA And PRIME Status From EMA For Investigational Ebola Zaire Vaccine (V920) 7/25/2016 8:28:07 AM
Following Revelations of ‘Flawed Studies’ in Clinical Trials, EMA Recommends Suspending Drugs; Many of Which Belong to Novartis AG (NVS) and Teva (TEVA) 7/25/2016 6:50:43 AM